Busulfan Fresenius Kabi 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
IB/0020 
C.I.2.a - Change in the SPC, Labelling or PL of a 
26/04/2021 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
amended 
on 
SmPC, Annex 
II and PL 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
IA/0019/G 
This was an application for a group of variations. 
13/01/2021 
n/a 
B.III.1.a.2 - Submission of a new/updated or 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
B.III.1.a.2 - Submission of a new/updated or 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
IA/0018 
A.7 - Administrative change - Deletion of 
08/12/2020 
manufacturing sites 
Annex II and 
PL 
IA/0017 
B.III.1.a.2 - Submission of a new/updated or 
03/12/2020 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
IAIN/0016 
C.I.3.a - Change(s) in the SPC, Labelling or PL 
29/07/2020 
SmPC and PL 
intended to implement the outcome of a procedure 
concerning PSUR or PASS or the outcome of the 
assessment done under A 45/46 - Implementation of 
wording agreed by the competent authority 
IA/0015 
B.I.b.1.d - Change in the specification parameters 
07/07/2020 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
Page 2/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II/0014 
B.II.d.1.e - Change in the specification parameters 
19/09/2019 
n/a 
and/or limits of the finished product - Change 
outside the approved specifications limits range 
R/0010 
Renewal of the marketing authorisation. 
26/04/2019 
20/06/2019 
SmPC, Annex 
Based on the review of data on quality, safety and efficacy, 
II, Labelling 
the CHMP considered that the benefit-risk balance of 
and PL 
Busulfan Fresenius Kabi in the approved indication remains 
favourable and therefore recommended the renewal of the 
marketing authorisation with unlimited validity. 
IA/0013/G 
This was an application for a group of variations. 
06/06/2019 
n/a 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IAIN/0012 
B.II.b.2.c.1 - Change to importer, batch release 
22/03/2019 
20/06/2019 
Annex II and 
arrangements and quality control testing of the FP - 
Page 3/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
PL 
IB/0011 
B.II.e.z - Change in container closure system of the 
20/03/2019 
n/a 
Finished Product - Other variation 
IA/0009 
B.III.1.a.2 - Submission of a new/updated or 
11/01/2019 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
T/0008 
Transfer of Marketing Authorisation 
18/04/2018 
08/05/2018 
SmPC, 
Labelling and 
PL 
IB/0007 
B.II.b.4.a - Change in the batch size (including batch 
27/02/2018 
n/a 
size ranges) of the finished product - Up to 10-fold 
compared to the originally approved batch size 
IB/0006 
C.I.2.a - Change in the SPC, Labelling or PL of a 
19/12/2017 
08/05/2018 
SmPC, Annex 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
II and PL 
IB/0003/G 
This was an application for a group of variations. 
19/10/2017 
08/05/2018 
SmPC 
B.II.d.1.g - Change in the specification parameters 
and/or limits of the finished product - Addition or 
replacement (excluding biological or immunological 
Page 4/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
product) of a specification parameter wit its 
corresponding test method as a result of a safety or 
quality issue 
B.II.e.6.z - Change in any part of the (primary) 
packaging material not in contact with the finished 
product formulation - Other variation 
B.II.f.1.z - Stability of FP - Change in the shelf-life or 
storage conditions of the finished product - Other 
variation 
IA/0005 
B.III.1.a.2 - Submission of a new/updated or 
26/09/2017 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
IA/0004 
B.III.1.a.2 - Submission of a new/updated or 
26/09/2017 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
IA/0002 
B.III.1.a.2 - Submission of a new/updated or 
11/01/2016 
n/a 
deletion of Ph. Eur. Certificate of Suitability to the 
relevant Ph. Eur. Monograph - Updated certificate 
from an already approved manufacturer 
IB/0001 
C.I.2.a - Change in the SPC, Labelling or PL of a 
26/02/2015 
11/03/2015 
SmPC and PL 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
Page 5/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 6/6 
 
 
 
 
 
 
 
